PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
COKE vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between COKE and ABBV is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

COKE vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Coca-Cola Consolidated, Inc. (COKE) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
19.52%
4.59%
COKE
ABBV

Key characteristics

Sharpe Ratio

COKE:

1.37

ABBV:

0.46

Sortino Ratio

COKE:

2.27

ABBV:

0.73

Omega Ratio

COKE:

1.28

ABBV:

1.11

Calmar Ratio

COKE:

2.66

ABBV:

0.58

Martin Ratio

COKE:

7.07

ABBV:

1.45

Ulcer Index

COKE:

6.36%

ABBV:

7.60%

Daily Std Dev

COKE:

32.94%

ABBV:

23.69%

Max Drawdown

COKE:

-54.34%

ABBV:

-45.09%

Current Drawdown

COKE:

-4.55%

ABBV:

-13.89%

Fundamentals

Market Cap

COKE:

$10.85B

ABBV:

$315.43B

EPS

COKE:

$57.63

ABBV:

$2.87

PE Ratio

COKE:

21.48

ABBV:

62.20

PEG Ratio

COKE:

0.00

ABBV:

0.43

Total Revenue (TTM)

COKE:

$5.15B

ABBV:

$41.23B

Gross Profit (TTM)

COKE:

$2.06B

ABBV:

$30.76B

EBITDA (TTM)

COKE:

$844.78M

ABBV:

$17.62B

Returns By Period

In the year-to-date period, COKE achieves a 2.52% return, which is significantly higher than ABBV's -1.21% return. Over the past 10 years, COKE has outperformed ABBV with an annualized return of 30.67%, while ABBV has yielded a comparatively lower 15.15% annualized return.


COKE

YTD

2.52%

1M

1.74%

6M

19.52%

1Y

45.17%

5Y*

36.43%

10Y*

30.67%

ABBV

YTD

-1.21%

1M

1.26%

6M

4.59%

1Y

11.00%

5Y*

19.25%

10Y*

15.15%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

COKE vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COKE
The Risk-Adjusted Performance Rank of COKE is 8888
Overall Rank
The Sharpe Ratio Rank of COKE is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of COKE is 8686
Sortino Ratio Rank
The Omega Ratio Rank of COKE is 8383
Omega Ratio Rank
The Calmar Ratio Rank of COKE is 9494
Calmar Ratio Rank
The Martin Ratio Rank of COKE is 8888
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6464
Overall Rank
The Sharpe Ratio Rank of ABBV is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5656
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6060
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 7373
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6565
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

COKE vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Coca-Cola Consolidated, Inc. (COKE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for COKE, currently valued at 1.37, compared to the broader market-2.000.002.001.370.46
The chart of Sortino ratio for COKE, currently valued at 2.28, compared to the broader market-4.00-2.000.002.004.002.280.73
The chart of Omega ratio for COKE, currently valued at 1.28, compared to the broader market0.501.001.502.001.281.11
The chart of Calmar ratio for COKE, currently valued at 2.67, compared to the broader market0.002.004.006.002.670.58
The chart of Martin ratio for COKE, currently valued at 7.10, compared to the broader market0.0010.0020.007.101.45
COKE
ABBV

The current COKE Sharpe Ratio is 1.37, which is higher than the ABBV Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of COKE and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
1.37
0.46
COKE
ABBV

Dividends

COKE vs. ABBV - Dividend Comparison

COKE's dividend yield for the trailing twelve months is around 1.55%, less than ABBV's 3.58% yield.


TTM20242023202220212020201920182017201620152014
COKE
Coca-Cola Consolidated, Inc.
1.55%1.59%0.54%0.20%0.16%0.38%0.35%0.56%0.46%0.56%0.55%1.14%
ABBV
AbbVie Inc.
3.58%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

COKE vs. ABBV - Drawdown Comparison

The maximum COKE drawdown since its inception was -54.34%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for COKE and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-4.55%
-13.89%
COKE
ABBV

Volatility

COKE vs. ABBV - Volatility Comparison

Coca-Cola Consolidated, Inc. (COKE) has a higher volatility of 7.68% compared to AbbVie Inc. (ABBV) at 5.32%. This indicates that COKE's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
7.68%
5.32%
COKE
ABBV

Financials

COKE vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Coca-Cola Consolidated, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab